Patrizia Caretto

Title: Innovator Patrizia Caretto: Pioneering Heparin Derivatives

Introduction

Patrizia Caretto is a notable inventor based in Sesto S. Giovanni, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of heparin derivatives. With a total of 3 patents, her work focuses on innovative solutions to combat metastasis in cancer treatment.

Latest Patents

One of her latest patents involves heparin derivatives that possess antimetastatic activity. These derivatives are designed to inhibit the formation of metastases, which is crucial in cancer therapy. A specific series of these heparin derivatives are N-acylated with monocarboxylic or dicarboxylic acids, exhibiting molecular weights ranging from about 1000 Daltons to approximately 30,000 Daltons. Another series features average molecular weights between 1000 and 3000 Daltons and may also be N-acylated with residues from aliphatic monocarboxylic or dicarboxylic acids. Additionally, she has developed oligopeptides derived from C-reactive protein fragments, further showcasing her innovative approach to medical research.

Career Highlights

Patrizia Caretto is associated with Italfarmaco Spa, a company known for its commitment to pharmaceutical advancements. Her work at this institution has allowed her to focus on groundbreaking research that has the potential to change the landscape of cancer treatment.

Collaborations

Throughout her career, Patrizia has collaborated with esteemed colleagues such as Flavio Leoni and Gianni Gromo. These partnerships have fostered an environment of innovation and shared knowledge, contributing to the success of her projects.

Conclusion

Patrizia Caretto stands out as a pioneering inventor in the pharmaceutical industry, particularly in the development of heparin derivatives aimed at combating cancer metastasis. Her contributions and collaborations continue to influence the field positively.